The dyad model fosters collaboration between academic specialists and community oncologists, ensuring seamless patient care ...
The PAAG regimen significantly improved PFS and response rates in metastatic pancreatic cancer compared to chemotherapy alone ...
Racial and ethnic disparities in pancreatic cancer treatment and survival persist, with minority groups experiencing lower ...
SAN FRANCISCO -- Almost 80% of patients with heavily pretreated advanced/metastatic pancreatic cancer achieved disease ...
It's the question believers have asked for centuries when wars threaten nations, storms ravage cities and diseases strike loved ones: "Why, oh God, why?" ...
Pancreatic cancer is notoriously hard to treat, often resisting therapies that target its most common mutations. Researchers ...
To kick off 2026, PanCAN’s Volunteer Advisory Council shares a warm message of advice and encouragement with PanCAN ...
This weekend, friends and family of a local mixed martial arts fighter, who died from pancreatic cancer in 2025, will host a ...
Uncertain about how you can stay healthy on a tight budget, especially when bombarded with misinformation from social media ...
Surgery and chemotherapy together improved survival in GIST patients with liver metastases, increasing median cancer-specific ...
The FDA designates ARB1002 as an orphan drug, highlighting its potential as a novel treatment for pancreatic cancer amid ...
George K. Rahdert, a prominent and longstanding First Amendment attorney and defender, died in St. Petersburg Dec. 8. He was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback